Surgalign™ Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System
May 05 2022 - 9:00AM
Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care by
driving the evolution of digital health, today announced that the
Company’s HOLO Portal surgical guidance system has officially
entered clinical use. The first procedure was performed at Indiana
Spine Hospital in Carmel, Indiana by Dr. Mario Brkaric, a
board-certified orthopedic surgeon.
The HOLO Portal system is the world’s first surgical guidance
system incorporating AI and AR and the first clinical application
of Surgalign’s HOLO™ AI digital health platform. HOLO Portal’s
convolutional neural networks process intraoperative images to
autonomously identify patient anatomy and plan patient-specific
pedicle screw trajectories approved by the surgeon. The system then
displays the anatomy and pinpoints the trajectories for ease of
placement, using the AR display.
In January 2022, the Company received U.S. Food & Drug
Administration (FDA) 510(k) clearance for the Portal system’s use
within lumbar spine procedures, and today, announced commencement
of clinical use. The Company has now moved into its limited market
release and intends to ramp up its site locations. As cases are
performed and data is accumulated, the Company also intends to
integrate new applications on its platform to advance the quality
of care and improve patient outcomes.
“HOLO Portal is a remarkably efficient technology in that its AI
autonomously labels anatomy and proposes a surgical plan from
intraoperative imaging. I then view the resulting guidance
information in 3D through its holographic display. This helps
ensure that every pedicle screw is precise in its size, trajectory,
and placement,” said Dr. Brkaric. “That improvement in surgical
precision can help lead to better patient outcomes and fewer
complications. This is groundbreaking technology, and I expect that
many more surgeons will adopt the HOLO Portal in our practice and
across the country.”
“Congratulations to Dr. Brkaric for completing the first
surgical case with the Surgalign HOLO Portal system,” said Dr. Rick
Sasso, founding member and President of Indiana Spine Group. “It’s
great to see the physicians at Indiana Spine Group adopting new
technologies and I look forward to adopting the HOLO AI
technology into my practice to drive better patient outcomes.”
“It’s an absolute honor to work with Indiana Spine Hospital and
Dr. Brkaric on the first clinical adoption of our HOLO™ AI
technology,” said Terry Rich, President and CEO of Surgalign. “This
is truly a foundational step in our new digital phase as we launch
the first of many planned AI technologies in our roadmap.”
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company
committed to the promise of digital health to drive transformation
across the surgical landscape. Uniquely aligned and resourced to
advance the standard of care, the company is building technologies
physicians and other health providers will look to for what is
truly possible for their patients. Surgalign is focused on
developing solutions that predictably deliver superior clinical and
economic outcomes. Surgalign markets products throughout the United
States and in more than 50 countries worldwide through an expanding
network of top independent distributors. Surgalign is headquartered
in Deerfield, IL, with commercial, innovation and design centers in
San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany.
Learn more at www.surgalign.com and connect on LinkedIn and
Twitter.
Forward Looking Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our products,
company, and industry, our management's beliefs, and certain
assumptions made by our management. Words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
and other variations of such words and similar expressions are
intended to identify such forward-looking statements.
Forward-looking statements include statements regarding the
features, capabilities and benefits of the HOLO Portal system.
These statements are not guarantees of future performance and are
subject to risks and uncertainties, including the risks described
in our public filings with the U.S. Securities and Exchange
Commission (SEC). Our actual results may differ materially from the
anticipated results reflected in these forward-looking statements.
Copies of the company's SEC filings may be obtained by contacting
the company or the SEC or by visiting Surgalign's website
at www.surgalign.com or the SEC's website
at www.sec.gov.
Investor and Media Contact: Mike Vallie
IR@surgalign.com+1 443 213 0499 |
Surgalign Contact:Kristine
Simmonsksimmons@surgalign.com+1 619 206 4648 |
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Sep 2023 to Sep 2024